Subtitle:

Antisense Oligodeoxynucleotides: from the Bench to the Patient

Publisher:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Description:

Polish - Japan Issue

Abstract:

In recent years, the antisense strategy for cancer therapy has progressed from in vitro culturestudies, to investigations in animal models, and now to clinical studies. We describe here thecurrent state of progress toward gene-directed antisense-based cancer therapy targetingBCR/ABL oncogene, primarily from the viewpoint of initial proof-of-concepts studies in animalmodels of human leukemias and phase I clinical investigations.

Relation:

Biotechnologia, vol.35, 4 (1996)-.

Volume:

35

Issue:

4

Start page:

108

End page:

115

Detailed Resource Type:

Article

Format:

application/pdf

Resource Identifier:

0860-7796 ; oai:rcin.org.pl:146559 ; IChB B-31

Source:

Library of Institute of Bioorganic Chemistry PAS

Language:

eng

Language of abstract:

eng

Temporal coverage:

1988-2010

Rights:

Creative Commons Attribution BY-SA 4.0 license

Terms of use:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitizing institution:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Original in:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Projects co-financed by:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Access:

Open